Labiana Health, S.A.

Research Labiana Health, S.A. (LAB.MC) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 75.18MEUR 2.57M-EUR 2.74M61.1%0.36EUR 5.91MEUR 36.67MEUR 5.08M
FY2024EUR 66.26MEUR 253.45KEUR 4.15M61.8%0.04EUR 6.74MEUR 35.39MEUR 2.87M
FY2023EUR 58.46M-EUR 4.42M-EUR 4.68M58.7%-0.61EUR 2.96MEUR 41.72MEUR 3.58M
FY2022EUR 57.85M-EUR 8.94M-EUR 774.37K56.4%-1.24EUR 2.52MEUR 38.20MEUR 7.03M
FY2021EUR 56.96M-EUR 1.78M-EUR 858.72K61.4%-0.25EUR 3.28MEUR 44.76MEUR 11.59M

About Labiana Health, S.A.

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, and bacterial vaccines; and Fosfomycin trometamol under the Fosfomicina Labiana brand name.

Related stock research

Other Healthcare stocks

Frequently asked questions

What does Labiana Health, S.A. do?

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, and bacterial vaccines; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments, quality system and manufacturing services.